Adjuvant immune checkpoint inhibitors across solid tumors: a meta-analysis of phase II-III randomized trials.
- DOI
- 10.3389/fonc.2026.1903546
- Published
- 2026
- Container
- Frontiers in oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fonc.2026.1903546,
title = {Adjuvant immune checkpoint inhibitors across solid tumors: a meta-analysis of phase II-III randomized trials.},
author = {Polito MG and Sisca L and Caruso D and Cosimati A and Ramirez Reinaga CA and Leka E and Santini D and Spinelli GP},
year = {2026},
journal = {Frontiers in oncology},
doi = {10.3389/fonc.2026.1903546},
url = {https://doi.org/10.3389/fonc.2026.1903546}
}RIS
TY - JOUR TI - Adjuvant immune checkpoint inhibitors across solid tumors: a meta-analysis of phase II-III randomized trials. AU - Polito MG AU - Sisca L AU - Caruso D AU - Cosimati A AU - Ramirez Reinaga CA AU - Leka E AU - Santini D AU - Spinelli GP PY - 2026 JO - Frontiers in oncology DO - 10.3389/fonc.2026.1903546 UR - https://doi.org/10.3389/fonc.2026.1903546 ER -
APA
MG, P., L, S., D, C., A, C., CA, R. R., E, L., D, S., & GP, S. (2026). Adjuvant immune checkpoint inhibitors across solid tumors: a meta-analysis of phase II-III randomized trials.. Frontiers in oncology. https://doi.org/10.3389/fonc.2026.1903546
Source records
- pubmed · retrieved 2026-09-25T00:19:22.027Z
- europe-pmc · retrieved 2026-09-25T00:19:22.044Z
- doaj · retrieved 2026-09-25T00:19:22.031Z